Quanterix vs 10x Genomics
QTRX and TXG side by side, both in laboratory apparatus and analytical, optical, measuring, and controlling instruments. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How QTRX and TXG compare
10x Genomics is the larger company, worth 66 times as much as Quanterix ($9.1B against $137M).
Quanterix grew revenue faster over the last twelve months (22.0% versus −4.3% for 10x Genomics).
10x Genomics keeps more of each dollar of sales as profit, with a net margin of −12.2% compared with −80.2% at Quanterix.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | QTRX | TXG |
|---|---|---|
| Size and price | ||
| Market cap | $137M | $9.1B |
| Share price | $2.90 | $70.11 |
| Change, 1 year | −43.8% | 443% |
| Change, 5 years | −94.9% | −60.6% |
| Beta (5Y) | 1.34 | 2.05 |
| Employees | 450 | 1,178 |
| StockData Score | ||
| Total score | 9 | 9 |
| Valuation score | 3 (better) | 0 |
| Growth score | 1 | 2 (better) |
| Performance score | 0 | 1 (better) |
| Health score | 5 | 6 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 0.9× (better) | 14.8× |
| P/B | 0.6× (better) | 11.1× |
| P/FCF | – | 75.2× |
| FCF yield | −59.5% | 1.3% (better) |
| Fair value | $12.26 | $26.97 |
| Margin of safety | 76.3% (better) | −160% |
| Growth | ||
| Revenue growth (TTM) | 22.0% (better) | −4.3% |
| Revenue growth, 5Y average | 10.0% | 16.6% (better) |
| Profitability | ||
| Gross margin | 42.7% | 70.0% (better) |
| Operating margin | −99.6% | −14.3% (better) |
| Net margin | −80.2% | −12.2% (better) |
| FCF margin | −53.2% | 19.7% (better) |
| Return on equity | −46.5% | −9.4% (better) |
| Return on invested capital | −138% | −23.3% (better) |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 3.40 | 5.69 (better) |
| Altman Z-score | −2.46 | 25.67 (better) |
| Piotroski F-score | 3 | 6 (better) |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 68.0% | 98.7% |
| Held by insiders | 12.2% | 4.3% |
| Insider net buying, 12 months | $296K (better) | −$16.9M |
| Superinvestors holding | – | 1 |
| Short interest, % of float | 12.2% | 12.3% |
Go deeper
- QTRX stock overview
- QTRX income statement
- QTRX valuation and score
- TXG stock overview
- TXG income statement
- TXG valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.